Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 5 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $25K, and 3 sales totalling $308K. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 14, 2026 | Ben Yong Director | −$15,683 | 2,000 | −18% | Yes | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 16, 2026 | Nicacio Leonardo Viana Chief Medical Officer | $0 | 250,009 | +44% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 11, 2026 | Saxena Nishant C Chief Business Officer | +$25,036 | 2,600 | +3% | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 7, 2026 | Cohen Yuval Chief Executive Officer | −$171,396 | 17,000 | −10% | Yes | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 7, 2026 | Moran Sean F. Chief Financial Officer | −$120,971 | 12,000 | −12% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free